Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lloyd Jones

Showing results (61-70 of 733) with videos related to

Pageof 74
Sort By:
JAMA|July 20, 2021
Novel Lipid-Lowering Therapies to Reduce Cardiovascular RiskJohn T Wilkins, Donald M Lloyd-Jones
Nature Reviews. Cardiology|January 9, 2013
Adding a life-course perspective to cardiovascular-risk communicationKunal N Karmali, Donald M Lloyd-Jones
The New England Journal of Medicine|March 17, 2015
Lowering LDL cholesterol is good, but how and in whom?Neil J Stone, Donald M Lloyd-Jones
Health Technology Assessment (Winchester, England)|February 13, 2009
Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluationH Pilgrim, M Lloyd-Jones, A Rees
Nature Reviews. Cardiology|May 17, 2016
Prevention: HOPE-3 trial - targeting BP and LDL-C in at-risk patientsJohn T Wilkins, Donald M Lloyd-Jones
Journal of the American Heart Association|April 26, 2017
Implementing Cardiovascular Risk Prediction in Clinical Practice: The Future Is NowKunal N Karmali, Donald M Lloyd-Jones
Health Technology Assessment (Winchester, England)|July 2, 2009
Docetaxel for the adjuvant treatment of early node-positive breast cancer: a single technology appraisalJ Chilcott, M Lloyd Jones, A Wilkinson
JAMA|July 29, 2024
Statins for Primary Prevention of Cardiovascular Disease-With PREVENT, What's a Clinician to Do?Sadiya S Khan, Donald M Lloyd-Jones
Journal of Wound Care|September 21, 2010
Living with wound-associated pain: impact on the patient and what clinicians really thinkM Lloyd Jones, M Greenwood, A Bielby
Cardiology in Review|April 8, 2016
Association of Traditional Cardiovascular Risk Factors With Development of Major and Minor Electrocardiographic Abnormalities: A Systematic ReviewCaroline F Healy, Donald M Lloyd-Jones
Pageof 74

Showing results (61-70 of 733) with videos related to

Sort By:
Pageof 74
JAMA|July 20, 2021
Novel Lipid-Lowering Therapies to Reduce Cardiovascular RiskJohn T Wilkins, Donald M Lloyd-Jones
Nature Reviews. Cardiology|January 9, 2013
Adding a life-course perspective to cardiovascular-risk communicationKunal N Karmali, Donald M Lloyd-Jones
The New England Journal of Medicine|March 17, 2015
Lowering LDL cholesterol is good, but how and in whom?Neil J Stone, Donald M Lloyd-Jones
Health Technology Assessment (Winchester, England)|February 13, 2009
Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluationH Pilgrim, M Lloyd-Jones, A Rees
Nature Reviews. Cardiology|May 17, 2016
Prevention: HOPE-3 trial - targeting BP and LDL-C in at-risk patientsJohn T Wilkins, Donald M Lloyd-Jones
Journal of the American Heart Association|April 26, 2017
Implementing Cardiovascular Risk Prediction in Clinical Practice: The Future Is NowKunal N Karmali, Donald M Lloyd-Jones
Health Technology Assessment (Winchester, England)|July 2, 2009
Docetaxel for the adjuvant treatment of early node-positive breast cancer: a single technology appraisalJ Chilcott, M Lloyd Jones, A Wilkinson
JAMA|July 29, 2024
Statins for Primary Prevention of Cardiovascular Disease-With PREVENT, What's a Clinician to Do?Sadiya S Khan, Donald M Lloyd-Jones
Journal of Wound Care|September 21, 2010
Living with wound-associated pain: impact on the patient and what clinicians really thinkM Lloyd Jones, M Greenwood, A Bielby
Cardiology in Review|April 8, 2016
Association of Traditional Cardiovascular Risk Factors With Development of Major and Minor Electrocardiographic Abnormalities: A Systematic ReviewCaroline F Healy, Donald M Lloyd-Jones
Pageof 74